Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nanfang Hospital, Southern Medical University
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients undergoing completely resection of EGRF mutation-positive NSCLC Staging IIB to ⅢA, N1-2; PS = 0 or 1; Adequate hematological, biochemical and organ functions
You may not be if
Systemic anticancer therapy prior to surgery, other malignancies before or during the study, any unstable illness, women who were pregnant or lactating
Clareo Health | Adjuvant Chemotherapy With or Without Intercalated Icotinib
